Skip to content

Modified Tryptone Soya Broth with Novobiocin

by Oxoid Ltd EUDAMED

Active European Union

Ref EB1337E

Regulatory status

as of 27 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number5032384TSBNovobiocinV9 Basic UDI-DIDate3 Apr 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDR Active

Certificates

0 certificates · EUDAMED

No notified-body certificate is listed. Devices of this class are self-declared by the manufacturer.

Specification

EUDAMED

Device Name
Modified T.S.B. + Novobiocin
Model / Reference
EB1337E
Primary DI / UDI-DI
05032384511877
Basic UDI-DI
5032384TSBNovobiocinV9
EMDN Code
W0104010306 Culture media in bottles
Device Class
Class A
Market of Registration
Netherlands

Manufacturer details

EUDAMED SRN
GB-MF-000016914
Authorised representative
Thermo Fisher Diagnostics B.V. NL-AR-000013157

Other devices from Oxoid Ltd

See all devices from Oxoid Ltd →

Properties

  • Animal Tissues
  • Microbial Substances
  • Reagent
  • Professional Testing

Other properties (7)

  • Sterile: No
  • Human Tissues: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No
  • New Device: No